QNTM

Quantum Biopharma Ltd. QNTM

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.3M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$1.50M total
Reading the latest SEC filing…

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Financial Trends

Revenue & Net Income

13fpro.ai/company/QNTM

Loading ratio trend…

About Quantum Biopharma Ltd. (QNTM): stock profile, AI score and financials

Quantum Biopharma Ltd. (QNTM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. QNTM is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.3m in revenue and is scored on the micro-cap board instead. Top institutional holders of QNTM by reported 13-F value include AdvisorShares Investments, JANE STREET GROUP, Platform Technology Partners, based on the most recent SEC filings. QNTM trades on the Nasdaq exchange and files with the SEC under CIK 1771885. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QNTM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quantum Biopharma Ltd. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1771885 →